Y. Li et al. found that ovarian cancer patients with high STAT4 expression had a worse prognosis compared to those with low STAT4 expression, noting a significant upregulation of STAT4 in cancerous tissues compared to normal ones. The gene discussed is STAT4; the disease is ovarian cancer.